Financials [ 7/12 ] | Capital Markets [ 34/74 ]
NASDAQ | Common Stock
Drugs Made In America Acquisition II Corp. does not have significant operations.
The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
It intends to source and evaluate companies focused on the pharmaceutical sector.
Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 18, 25 | 0.00 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | N/A Decreased by N/A% | 4.33 M Increased by +7.40 K% | - - |
| Dec 31, 25 | 0.00 Decreased by N/A% | 4.33 M Increased by +10.49 K% | Increased by +N/A% - |
| Sep 30, 25 | 0.00 - | -46.16 K - | Decreased by N/A% - |
| Jun 30, 25 | 0.00 - | -38.07 K - | Decreased by N/A% - |
| Mar 31, 25 | 0.00 - | -59.33 K - | Decreased by N/A% - |
| Sep 30, 24 | N/A - | -41.68 K - | - - |